UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2

Blood, 2019-12, Vol.134 (25), p.2261-2270

2019

Link zum Volltext

Verfügbarkeit prüfen

Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma

Blood, 2014-03, Vol.123 (13), p.2062-2065

2014

Link zum Volltext

Verfügbarkeit prüfen

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma

Blood, 2012-03, Vol.119 (9), p.1963-1971

2012

Link zum Volltext

Verfügbarkeit prüfen

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma

Nature genetics, 2014-04, Vol.46 (4), p.329-335

2014

Link zum Volltext

Verfügbarkeit prüfen

Meningococcal Porin PorB Binds to TLR2 and Requires TLR1 for Signaling

Journal of Immunology, 2006-02, Vol.176 (4), p.2373-2380

2006

Link zum Volltext

Verfügbarkeit prüfen

Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor-1 in childhood obesity: evidence of a procoagulant state

British journal of haematology, 2012-08, Vol.158 (4), p.523-527

2012

Link zum Volltext

Verfügbarkeit prüfen

Meningococcal Porin PorB Prevents Cellular Apoptosis in a Toll-Like Receptor 2- and NF-κB-Independent Manner

Infection and Immunity, 2010-03, Vol.78 (3), p.994-1003

2010

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral T‐cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B‐cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R‐CHOP) chemoimmunotherapy

Clinical & translational immunology, 2021, Vol.10 (11), p.e1351-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Genetic aberrations of NLRC5 are associated with downregulated MHC‐I antigen presentation and impaired T‐cell immunity in follicular lymphoma

EJHaem, 2020-11, Vol.1 (2), p.517-526

2020

Link zum Volltext

Verfügbarkeit prüfen

Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions

British journal of haematology, 2019-04, Vol.185 (1), p.25-41

2019

Link zum Volltext

Verfügbarkeit prüfen

Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration

Journal of clinical oncology, 2019-12, Vol.37 (34), p.3300-3309

2019

Link zum Volltext

Verfügbarkeit prüfen

A coordinated strategy for a simple, pragmatic approach to the early identification of the ultra‐high‐risk patient with diffuse large B‐cell lymphoma

Internal medicine journal, 2023-07, Vol.53 (7), p.1105-1109

2023

Link zum Volltext

Verfügbarkeit prüfen

The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma

European journal of haematology, 2019-09, Vol.103 (3), p.200-207

2019

Link zum Volltext

Verfügbarkeit prüfen

Reply to M. Sorigue

Journal of clinical oncology, 2020-02, Vol.38 (6), p.648-649

2020

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment of Epstein–Barr virus–associated primary central nervous system lymphoma due to post‐transplantation lymphoproliferative disorder, with ibrutinib and third‐party Epstein–Barr virus–specific T cells

American journal of transplantation, 2021-10, Vol.21 (10), p.3465-3471

2021

Link zum Volltext

Verfügbarkeit prüfen

B2M Gene Expression Reflects an Immunologically Active Tumor Microenvironment in DLBCL

Blood, 2019-11, Vol.134 (Supplement_1), p.2778-2778

2019

Link zum Volltext

Verfügbarkeit prüfen

The IRE1-XBP1s Pathway Impairment Underpins NK Cell Dysfunction in Hodgkin Lymphoma, That Is Partly Restored By PD-1 Blockade

Blood, 2019-11, Vol.134 (Supplement_1), p.2795-2795

2019

Link zum Volltext

Verfügbarkeit prüfen

Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma

Cell reports (Cambridge), 2020-05, Vol.31 (5), p.107522, Article 107522

2020

Link zum Volltext

Verfügbarkeit prüfen

The NLPHL Tumor Microenvironment Is Markedly Enriched in the Tigit and PD-1 Signalling Axes Compared to Classical Hodgkin Lymphoma

Blood, 2021-11, Vol.138 (Supplement 1), p.3513-3513

2021

Link zum Volltext

Verfügbarkeit prüfen

The Tumor Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma Is a Unique Immunobiological Entity Distinct from Classical Hodgkin Lymphoma

Blood, 2018-11, Vol.132 (Supplement 1), p.4123-4123

2018

Link zum Volltext

Verfügbarkeit prüfen

Intra-Tumoral CD8+ T-Cells in Follicular Lymphoma Contain Large Clonal Expansions That Are Amenable to Dual-Checkpoint Blockade

Blood, 2019-11, Vol.134 (Supplement_1), p.2793-2793

2019

Link zum Volltext

Verfügbarkeit prüfen

Neoantigens Are Typically Associated with Intact HLA Class I Presentation in Early-Stage Follicular Lymphoma

Blood, 2020-11, Vol.136 (Supplement 1), p.37-38

2020

Link zum Volltext

Verfügbarkeit prüfen

Correction for Massari et al., meningococcal porin PorB prevents cellular apoptosis in a Toll-like receptor 2- and NF-κB-independent manner

Infection and immunity, 2015-08, Vol.83 (8), p.3339-3339

2015

Link zum Volltext

Verfügbarkeit prüfen

Whole-Blood Tissue Factor Procoagulant Activity Is Elevated in Type 1 Diabetes: Effects of hyperglycemia and hyperinsulinemia

Diabetes care, 2012-06, Vol.35 (6), p.1322-1327

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(42)
Berichte
(1)

Sprache

Englisch
(43)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2

Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma

Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation

Meningococcal Porin PorB Binds to TLR2 and Requires TLR1 for Signaling

Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor-1 in childhood obesity: evidence of a procoagulant state

Meningococcal Porin PorB Prevents Cellular Apoptosis in a Toll-Like Receptor 2- and NF-κB-Independent Manner

Intratumoral T‐cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B‐cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R‐CHOP) chemoimmunotherapy

Genetic aberrations of NLRC5 are associated with downregulated MHC‐I antigen presentation and impaired T‐cell immunity in follicular lymphoma

Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions

Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration

A coordinated strategy for a simple, pragmatic approach to the early identification of the ultra‐high‐risk patient with diffuse large B‐cell lymphoma

The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma

Reply to M. Sorigue

Successful treatment of Epstein–Barr virus–associated primary central nervous system lymphoma due to post‐transplantation lymphoproliferative disorder, with ibrutinib and third‐party Epstein–Barr virus–specific T cells

B2M Gene Expression Reflects an Immunologically Active Tumor Microenvironment in DLBCL

The IRE1-XBP1s Pathway Impairment Underpins NK Cell Dysfunction in Hodgkin Lymphoma, That Is Partly Restored By PD-1 Blockade

Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma

The NLPHL Tumor Microenvironment Is Markedly Enriched in the Tigit and PD-1 Signalling Axes Compared to Classical Hodgkin Lymphoma

The Tumor Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma Is a Unique Immunobiological Entity Distinct from Classical Hodgkin Lymphoma

Intra-Tumoral CD8+ T-Cells in Follicular Lymphoma Contain Large Clonal Expansions That Are Amenable to Dual-Checkpoint Blockade

Neoantigens Are Typically Associated with Intact HLA Class I Presentation in Early-Stage Follicular Lymphoma

Correction for Massari et al., meningococcal porin PorB prevents cellular apoptosis in a Toll-like receptor 2- and NF-κB-independent manner

Whole-Blood Tissue Factor Procoagulant Activity Is Elevated in Type 1 Diabetes: Effects of hyperglycemia and hyperinsulinemia

Suchergebnisse filtern